Physician profile
Derrick A Christopher
NPI 1427374891
$11,651.45
in general payments reported to CMS, 2019-2025
8 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,119 · 2020: $197 · 2021: $189 · 2023: $2,236 · 2024: $4,460 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,608 · Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,608.21 |
| Food and Beverage | $538.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,576.34 | 2019-2024 | Da Vinci Surgical System |
| Transmedics, INC. | $4,372.68 | 2024 | Organ Care System |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $205.58 | 2025 | |
| Organox LTD | $135.29 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $124.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $110.93 | 2025 | Terlivaz |
| Conmed Corporation | $75.18 | 2019 | |
| Paragonix Technologies, INC. | $51.44 | 2024 | Lungguard, Baroguard, Liverguard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.